Tag Archives: Médecins Sans Frontières

Will India hold on to its status as ‘Pharmacy of the developing world’?

Posted on February 19, 2012 by

Friday , February 17, 2012 Source: IBN Live On a day when television channels stayed focused on the fallout of the ongoing tussle between the Army Chief and the Government, hundreds of people gathered at the hallowed ground for protests … Continue reading →

Posted in EU-India FTA | Tagged , | 1 Comment

Brazilians demand greater access to crucial HIV drug

Posted on November 14, 2011 by

Source: www.msfaccess.org Civil society files patent opposition to increase access to HIV/AIDS medicines Rio de Janeiro, 10 November 2011 – Brazilian civil society will oppose a patent application today for the key HIV drug lopinavir/ritonavir (LPV/r), in an effort to … Continue reading →

Posted in Patent Opposition | Tagged , , , | Leave a comment

MSF-Japan :Access to life-saving generic medicines threatened by trans-pacific partnership trade agreement

Posted on November 7, 2011 by

Japan Must Consider The Impact of Trans-Pacific Partnership Agreement on Access To Medicines In Developing Countries The Trans-Pacific Partnership (TPP) agreement has the potential to greatly diminish access to affordable medicines for millions of people in parts of the developing … Continue reading →

Posted in Generic drug, GFATM, TPPA, Trans-Pacific Partnership Agreement | Tagged , | Leave a comment

Slideshow on Pharmacy to the Developing World May Shut Shop: IBSA News

Posted on September 23, 2011 by

IBSA News, Sep 19 2011 India’s generic drugs are a lifeline not only for millions of poor people in India, but also to developing countries in Africa, Asia and Latin America. So much so that India is known as the … Continue reading →

Posted in EU-India FTA, Generic drug, HIV/Aids, TRIPS | Tagged , | Leave a comment

Novartis executive to join Gates foundation

Posted on September 14, 2011 by

Novartis executive to join Gates foundation Financial Times By Andrew Jack in London, 14 September 2011 A top executive at Novartis is to join the Bill & Melinda Gates Foundation, cementing strong co-operation between leading pharmaceuticals companies and the world’s … Continue reading →

Posted in Drug Pricing, Generic drug, patent evergreening | Tagged , , , , | Leave a comment

A victory for Novartis could spell death for millions

Posted on September 7, 2011 by

Source: The Hindu PRISCILLA JEBARAJ Sepetember 6,2001 The Swiss pharma giant fighting in Supreme Court for patent on anti-cancer drug A case being heard in the Supreme Court on Tuesday could signal a death sentence for Loon Gangte. Mr. Gangte … Continue reading →

Posted in Drug Pricing, Indian Patent Law, patent evergreening, Sec 3 (d) | Tagged , , , , | 1 Comment

Press: Africa’s Aids patients biggest losers if India/EU drugs deal sails through

Posted on February 28, 2011 by

Source: The East African, 28.2.2011, by Jeff Otieno Jimmy Gideyi has been on free antiretroviral generic drugs manufactured in India since 2004, when he was confirmed HIV positive. In the past decade, the 56-year-old man has received a constant supply … Continue reading →

Posted in EU-India FTA | Tagged , , , , , , , | Leave a comment

Press: Monopoly on pesticide test data set to be extended to 5 years

Posted on February 24, 2011 by

Source: Economic Times, 24.2.2011 NEW DELHI: The government has proposed an increase in the monopoly period enjoyed by pesticide manufacturers over test data , used to support claims for the efficacy of their products, to five years. The proposals form … Continue reading →

Posted in EU-India FTA | Tagged , , , , | Leave a comment

Press: Kenya joins drive to block new EU policy on ARVs

Posted on February 8, 2011 by

Source: Standard Media, 08.02.2011, by John Oywa Kenya has been sucked into a global campaign to block the European Union from implementing a new policy on Aids drugs. The controversial move could restrict access to cheaper anti-retroviral drugs (ARVs) by … Continue reading →

Posted in EU-India FTA | Tagged , , , , , , | Leave a comment

Press: UN: EU-India free-trade agreement would hurt health of millions

Posted on February 7, 2011 by

Source: Vancouversun, 04.02.2011, by Peter O’Neil PARIS — A proposed European Union-India free-trade agreement would deny millions of people around the world the chance to access life-saving and life-extending drugs cheaply, according to the United Nations’ special rapporteur on the … Continue reading →

Posted in EU-India FTA | Tagged , , , , , , | Leave a comment